Less than 25 percent of adults with overweight or obesity without diabetes remain on any glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment after 12 months, according to a research letter ...

Medically reviewed by Lindsay Cook, PharmD Key Takeaways About 14% of people developed a vitamin D deficiency after one year ...

On his way to the GQ Bowl, Nate Burleson makes a barbershop stop and gets real about what athletes should prioritize: nutrition, injury recovery, and quality sleep. He also shares why he’s teaming up ...

Adding almonds to the diet of adults with obesity enhances inflammatory cytokine profiles and diet quality, highlighting a simple anti-inflammatory strategy.

Vermont topped a new ranking of the best states for senior health and well-being; Older adults in the Green Mountain State ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

More adults younger than 50 are being diagnosed with colorectal cancer. Early-onset cases are expected to more than double in the next decade. Dr. Shahnaz Sultan, a Gastroenterology professor at the ...

Adults with overweight or obesity regained most weight lost during GLP-1 receptor agonist treatment at 1 year following cessation.

GLP-1 drugs like Ozempic and Wegovy aid in weight loss by suppressing appetite. Researchers are looking next at how the body expends energy – including through fat.

Post-diagnosis weight gain over ~1.5 years is consistently associated with increased breast cancer–specific and all-cause mortality across meta-analyses. How GLP-1 weight-loss drugs fit after breast ...

Treatment with GLP-1 RAs for T2D and obesity is independently associated with an increased risk for osteoporosis, gout, and osteomalacia.

The true share of overweight SNAP recipients could be higher, since the analysis assumes accurate weight reporting to the DMV. That said, other health data show that roughly six in ten Nevada adults ...